from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1123c/bpoB

LFCtreatmentdescriptionclass of inhibitor

0.089

Amikacinug/mL Amikacintranslation

-0.659

Cap5-10ug/mL Capreomycintranslation

-0.189

Rox10-50 ug/mL Roxithromycintranslation

0.408

SM2-5 ug/mL Streptomycintranslation

-0.501

Tet5-10 ug/mL Tetracyclinetranslation

-0.024

Rif0.2-5ug/mL Rifampicintranscription

0.036

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.884

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.741

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.083

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.856

Clofazimine10-13 ug/mL Clofaziminerespiration

1.350

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.998

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.253

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.592

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.828

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.703

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.581

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.437

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.998

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.127

KCN5-20 ug/mL Potassium cyaniderespiration

1.135

NaN30.2-2 mM Sodium aziderespiration

-0.856

Nigericin50 uM Nigericinrespiration

0.065

TRC10-150 ug/mL Triclosanrespiration

0.345

TRZ10-25 ug/mL Thioridazinerespiration

-0.694

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.059

menadione6-10 ug/mL Menadionerespiration

-0.396

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.014

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.127

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.367

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.596

NRP_1Non-replicating persistence stage 1dosRassociated

-0.640

Amp0.2mg/mL AmpicillincellWall

0.069

Cephalexin20-100 ug/mL CephalexincellWall

0.469

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.187

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.442

EMB10-20 ug/mL EthambutolcellWall

-0.672

Eta12-40 ug/mL EthionamidecellWall

-0.119

INH0.2-0.4 ug/mL IsoniazidcellWall

0.107

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.488

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.692

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.182

BZA0.12 mg/mL BenzamidearomaticAmides

0.003

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.431

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.131

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.216

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.449

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.236

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.156

UVUV-irradiationDNAdamaging

-1.113

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.257

Antimycin12.5-50 ug/mL Antimycin A?

-0.232

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.259

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.692

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.732

PA8240.2-2 ug/mL PA-824?

0.228

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.777

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.109

Verapamil50 uM Verapamil?

0.234

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.461

methoxatin10-20 ug/mL Methoxatin?